{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:38:49Z","timestamp":1757698729225},"reference-count":56,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Zentralbl Chir"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Zusamenfassung<\/jats:title><jats:p>Bronchiektasien, die nicht durch eine Zystische Fibrose bedingt sind, sind eine \u00e4tiologisch \u00e4u\u00dferst heterogene Erkrankung. Dieser Beitrag gibt einen \u00dcberblick \u00fcber die Ursachen, das diagnostische Vorgehen und die therapeutischen Optionen bei dieser nicht seltenen Lungenerkrankung.<\/jats:p>","DOI":"10.1055\/a-1361-2252","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T22:30:38Z","timestamp":1624314638000},"page":"346-358","source":"Crossref","is-referenced-by-count":1,"title":["Interdisziplin\u00e4re Behandlung der Non-Cystic-Fibrosis-Bronchiektasie \u2013 State of the Art"],"prefix":"10.1055","volume":"146","author":[{"given":"Pontus","family":"Mertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayan","family":"Merhej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Zardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1900499","DOI":"10.1183\/13993003.00499-2019","article-title":"Increasing bronchiectasis prevalence in Germany, 2009\u20132017: a population-based cohort study","volume":"54","author":"F C Ringshausen","year":"2019","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1802033","DOI":"10.1183\/13993003.02033-2018","article-title":"Economic burden of bronchiectasis in Germany","volume":"53","author":"R Diel","year":"2018","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-61452-6","volume-title":"Bronchiectasis. The EMBARC Manual","author":"J Chalmers","year":"2018"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1701289","DOI":"10.1183\/13993003.01289-2017","article-title":"Standardised classification of the aetiology of bronchiectasis using an objective algorithm","volume":"50","author":"D Ara\u00fajo","year":"2017","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"E Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"D Bilton","year":"2014","journal-title":"Thorax"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I","volume":"113","author":"A E O\u02bcDonnell","year":"1998","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1801269","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"R Boaventura","year":"2018","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1901333","DOI":"10.1183\/13993003.01333-2019","article-title":"Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series","author":"J Rademacher","year":"2019","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1164\/rccm.201809-1651oc","article-title":"Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis","volume":"200","author":"O Sibila","year":"2019","journal-title":"Am J Resp Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/nejmoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"P G Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1034\/j.1399-3003.1999.13e39.x","article-title":"Regulation of mucociliary clearance in health and disease","volume":"13","author":"E Houtmeyers","year":"1999","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1701926","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"G Mu\u00f1oz","year":"2018","journal-title":"Eur Respir J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.physio.2015.07.005","article-title":"Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial","volume":"102","author":"B Herrero-Cortina","year":"2016","journal-title":"Physiotherapy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/14038190802294856","article-title":"Active Cycles of Breathing Technique (ACBT) versus conventional chest physical therapy on airway clearance in bronchiectasis \u2013 A crossover trial","volume":"11","author":"N Syed","year":"2009","journal-title":"Adv Physiotherapy"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1183\/09031936.00055509","article-title":"A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis","volume":"34","author":"M P Murray","year":"2009","journal-title":"Eur Respir J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6\u200a% in non-cystic fibrosis bronchiectasis","volume":"106","author":"C HH Nicolson","year":"2012","journal-title":"Respir Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7\u200a% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"F Kellett","year":"2011","journal-title":"Respir Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1465-9921-15-44","article-title":"The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis \u2013 a randomised controlled trial","volume":"15","author":"A L Lee","year":"2014","journal-title":"Respir Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.apmr.2016.05.017","article-title":"Pulmonary Rehabilitation in Individuals With Non\u2013Cystic Fibrosis Bronchiectasis: A Systematic Review","volume":"98","author":"A L Lee","year":"2017","journal-title":"Arch Phys Med Rehab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.rmed.2012.08.004","article-title":"A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis","volume":"106","author":"P Mandal","year":"2012","journal-title":"Respir Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"A T Hill","year":"2017","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The Bronchiectasis Severity Index. An International Derivation and Validation Study","volume":"189","author":"J D Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"S Aliberti","year":"2016","journal-title":"Eur Respir J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"M J McDonnell","year":"2015","journal-title":"Respir Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s10096-019-03675-z","article-title":"Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis","volume":"38","author":"A Pieters","year":"2019","journal-title":"Eur J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jinf.2018.04.006","article-title":"Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences","volume":"77","author":"E Polverino","year":"2018","journal-title":"J Infection"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0042-101873","article-title":"Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Pr\u00e4vention \u2013 Update 2016*","volume":"70","author":"S Ewig","year":"2016","journal-title":"Pneumologie"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"A T Hill","year":"2019","journal-title":"Thorax"},{"issue":"S 64","key":"ref30","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1183\/13993003.congress-2020.2366","article-title":"Eradication of Pseudomonas aeruginosa within the baseline dataset of the German Bronchiectasis Registry PROGNOSIS","volume":"56","author":"P Mertsch","year":"2020","journal-title":"Eur Respir J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1600851","DOI":"10.1183\/13993003.00851-2016","article-title":"Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis","volume":"49","author":"E Valli\u00e8res","year":"2017","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/00325481.2017.1285677","article-title":"Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician","volume":"129","author":"C L Cramer","year":"2017","journal-title":"Postgrad Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"J Altenburg","year":"2013","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"C Wong","year":"2012","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"D J Serisier","year":"2013","journal-title":"JAMA"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline","volume":"71","author":"C L Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487oc","article-title":"Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non-Cystic Fibrosis Bronchiectasis","volume":"186","author":"J D Chalmers","year":"2012","journal-title":"Am J Resp Crit Care"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"C S Haworth","year":"2014","journal-title":"Am J Resp Crit Care"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"C S Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"A F Barker","year":"2014","journal-title":"Lancet Respir Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1702052","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"A D Soyza","year":"2018","journal-title":"Eur Respir J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1702053","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"T Aksamit","year":"2018","journal-title":"Eur Respir J"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1164\/rccm.201005-0756oc","article-title":"A Randomized Controlled Trial of Nebulized Gentamicin in Non-Cystic Fibrosis Bronchiectasis","volume":"183","author":"M P Murray","year":"2011","journal-title":"Am J Resp Crit Care"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis","volume":"162","author":"A F Barker","year":"2000","journal-title":"Am J Resp Crit Care"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jcf.2014.12.013","article-title":"A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients","volume":"14","author":"J S Elborn","year":"2015","journal-title":"J Cyst Fibros"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jcf.2015.12.004","article-title":"A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients","volume":"15","author":"P A Flume","year":"2016","journal-title":"J Cyst Fibros"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study","volume":"198","author":"D E Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"A Brodt","year":"2014","journal-title":"Eur Respir J"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/s2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"I F Laska","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/nejmoa2021713","article-title":"Phase 2\u2009Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"383","author":"J D Chalmers","year":"2020","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1749-8090-6-161","article-title":"A long term study assessing the factors influencing survival and morbidity in the surgical management of bronchiectasis","volume":"6","author":"A Sehitogullari","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1010-7940(03)00497-4","article-title":"Surgical Management of bronchiectasis: analysis and short-term results in 238 patients","volume":"24","author":"K Balkanli","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/thx.42.4.272","article-title":"Role of computed tomography in diagnosis of bronchiectasis","volume":"42","author":"J C Cook","year":"1987","journal-title":"Thorax"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3346\/jkms.2004.19.1.62","article-title":"Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis","volume":"19","author":"J H Lee","year":"2004","journal-title":"J Korean Med Sci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0003-4975(01)03085-5","article-title":"Current strategy for surgical management of bronchiectasis","volume":"72","author":"T Fujimoto","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"ref56","first-page":"300","volume-title":"Surgical Treatment of Bronchiectasis and Broncholithiasis","author":"J Deslauriers","year":"1998"}],"container-title":["Zentralblatt f\u00fcr Chirurgie - Zeitschrift f\u00fcr Allgemeine, Viszeral-, Thorax- und Gef\u00e4\u00dfchirurgie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1361-2252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T13:27:16Z","timestamp":1626355636000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1361-2252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":56,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,6,21]]},"published-print":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1361-2252","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-409X","1438-9592"],"issn-type":[{"value":"0044-409X","type":"print"},{"value":"1438-9592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}